Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 143,443 |
|
|||||
| News | - | ||||||
| Day High | 1.07 | Low High |
|||||
| Day Low | 0.9501 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Notable Labs Ltd | NTBL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0396 | 4.12% | 0.9997 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.97 | 0.9501 | 1.07 | 0.965 | 0.9601 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 549 | 143,443 | $ 0.9862316 | $ 141,468 | - | 0.833 - 5.27 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:22:24 | formt | 472 | $ 0.9997 | USD |
Notable Labs Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 8.66M | 9.02M | - | 658k | -32.3M | -3.58 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Notable Labs News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NTBL Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.95 | 1.07 | 0.9166 | 0.9676726 | 49,058 | 0.0497 | 5.23% |
| 1 Month | 1.79 | 1.84 | 0.833 | 1.18 | 60,475 | -0.7903 | -44.15% |
| 3 Months | 1.23 | 1.94 | 0.833 | 1.40 | 83,894 | -0.2303 | -18.72% |
| 6 Months | 2.85 | 4.24 | 0.833 | 1.46 | 118,168 | -1.85 | -64.92% |
| 1 Year | 4.50 | 5.27 | 0.833 | 1.64 | 120,439 | -3.50 | -77.78% |
| 3 Years | 4.50 | 5.27 | 0.833 | 1.64 | 120,439 | -3.50 | -77.78% |
| 5 Years | 4.50 | 5.27 | 0.833 | 1.64 | 120,439 | -3.50 | -77.78% |
Notable Labs Description
| Vascular Biogenics Ltd is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of first-in-class treatments for cancer. The lead product candidate of the company is VB-111 which is a gene-based biologic which is being developed for solid tumor indications for recurrent glioblastoma, an aggressive form of brain cancer. The company is also engaged in conducting a program targeting anti-inflammatory diseases, based on the use of Lecinoxoid platform technology. The product brands of the company include VTS, Vascular Targeting Systems, Vbl, Vascular Biogenics And Vascular Therapeutics. |
